INTEGRA LIFESCIENCES HOLDINGS CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $74.6m $64.7m $60.8m $50.2m $133.9m $169.1m $180.6m $67.7m ($6.9m) ($516.5m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $74.6m $64.7m
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $0 $0
Depreciation, Depletion and Amortization $72.7m $88.9m $110.7m $109.5m $116.0m $119.8m $118.3m $123.5m $140.9m $151.8m
Depreciation $31.2m $36.1m $44.1m $42.6m $42.1m $39.4m $40.1m $40.9m $42.4m $44.8m
Amortization $41.5m $52.8m $71.6m $72.8m $74.5m $83.3m $78.3m $82.8m $105.2m $107.1m
Amortization of Debt Issuance Costs $2.5m $2.7m $6.3m $5.4m $12.1m $7.0m $6.8m $6.2m $5.6m $5.6m
Amortization of Intangible Assets $13.9m $20.4m $21.2m $27.0m $27.8m $16.9m $13.9m $12.4m $21.3m $15.0m
Deferred Income Tax Expense (Benefit) ($6.5m) ($67.3m) ($8.2m) ($19.0m) ($64.1m) ($2.8m) ($4.6m) ($11.9m) ($20.7m) ($66.3m)
Share-based Payment Arrangement, Noncash Expense $17.3m $21.6m $20.8m $21.3m $19.6m $36.2m $27.7m $20.1m $24.4m $18.6m
Payment, Tax Withholding, Share-based Payment Arrangement $6.5m $5.1m $4.8m $24.6m $5.9m $3.5m $2.7m
Share-based Payment Arrangement, Expense $17.3m $21.6m $20.8m $21.3m $19.6m $36.2m $27.7m $20.1m $24.4m $18.6m
Goodwill, Impairment Loss $0 $511.4m
Impairment of Intangible Assets (Excluding Goodwill) $0
Impairment of Intangible Assets, Finite-lived $4.9m $5.8m $0 $2.8m $0 $0 $12.2m $511.4m
Share-based Payment Arrangement, Expensed and Capitalized, Amount $500k
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property ($1.8m) ($7.0m) ($1.4m) ($1.8m) $3.7m $3k $11.1m $0 $0 $490k
Gain (Loss) on Disposition of Business $2.6m $0 $0 $41.8m $644k $0 $0
Income Tax Expense (Benefit) $15.8m ($53.4m) ($3.4m) $9.9m ($40.4m) $45.6m $33.3m $13.3m ($11.3m) ($47.0m)
Interest Expense Nonoperating $70.6m $86.3m
Operating Lease, Expense $19.6m $19.7m $20.3m $22.6m $24.0m $24.3m $23.9m
Other Nonoperating Income (Expense) $845k $1.3m $8.3m $9.5m $4.4m $19.3m $12.0m $3.7m $3.9m ($2.4m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $17.5m $89.7m $17.0m $9.4m ($52.1m) ($7.3m) $33.9m ($4.6m) ($7.4m) $485k
Increase (Decrease) in Inventories $9.6m ($99k) ($8.3m) $43.3m $48.3m ($5.4m) $29.1m $59.8m $28.1m $46.8m
Proceeds from Stock Options Exercised $10.5m $9.8m $9.4m $6.9m $5.2m $6.8m $5.5m $4.3m $6.4m $957k
Accretion Expense $8.1m $0 $0 $15.4m $0 $0
Foreign Currency Transaction Gain (Loss), Realized ($2.9m) $1.7m ($300k) ($1.6m) $100k ($3.3m) ($4.4m) ($2.3m) ($7.4m)
Goodwill $510.6m $937.9m $926.5m $954.3m $932.4m $1.0b $1.0b $1.1b $1.1b $615.2m
Investment Income, Interest $24k $255k $2.8m $10.8m $9.3m $6.7m $11.9m $17.2m $20.0m $18.5m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement ($602k) $102k ($51k) $0 $0 $144k $13k
Net Cash Provided by (Used in) Operating Activities $116.4m $114.5m $199.7m $231.4m $203.8m $312.4m $264.5m $140.0m $129.4m $50.4m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $47.3m $43.5m $77.7m $69.5m $38.9m $48.0m $42.3m $66.9m $104.4m $81.4m
Payments to Acquire Businesses, Net of Cash Acquired ($225k) $1.2b $30.5m
Payments to Acquire Investments $32.7m $49.0m $8.5m
Gain (Loss) on Sale of Investments ($2.3m)
Payments for (Proceeds from) Other Investing Activities $0
Net Cash Provided by (Used in) Investing Activities ($42.6m) ($1.2b) ($49.7m) ($162.7m) ($68.1m) ($161.4m) ($58.6m) ($94.2m) ($390.8m) ($108.1m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $0 $0 $349.6m $0 $0
Payments for Repurchase of Common Stock $100.0m $0 $125.0m $275.0m $52.5m $221k
Net Cash Provided by (Used in) Financing Activities ($15.1m) $1.2b ($180.9m) ($8.8m) $121.6m ($98.2m) ($252.0m) ($229.9m) $237.9m $28.3m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($4.7m) $10.7m ($5.2m) $74k $13.9m ($9.5m) ($10.7m) $3.9m ($6.5m) $18.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($4.7m) $10.7m ($5.2m) $60.1m $271.3m $43.3m ($56.8m) ($180.3m) ($30.0m) ($11.3m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $198.9m $470.2m $513.4m $456.7m $276.4m $246.4m $235.0m
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net ($4.9m) ($7.1m) ($7.8m) ($6.5m) ($5.1m) ($4.8m) ($24.6m) ($5.9m) ($3.5m) $17.2m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.